Asia Pacific Hyaluronic Acid Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2030 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | USD 2,584.42 |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>Markt für Hyaluronsäure im asiatisch-pazifischen Raum nach Qualität (kosmetische und pharmazeutische Qualität), Typ (hydrolysierte Hyaluronsäure, natriumacetylierte Hyaluronsäure und Natriumhyaluronat), Anwendung (Ästhetik, Osteoarthritis, pharmazeutische API, Kosmetik , Augenheilkunde und andere), Endbenutzer (medizinische Spas und Schönheitszentren, dermatologische Kliniken und Zentren für kosmetische Chirurgie), Vertriebskanal (direkte Ausschreibung und Einzelhandelsverkauf), Branchentrends und Prognose bis 2030.
Marktanalyse und Einblicke für Hyaluronsäure im asiatisch-pazifischen Raum
Hyaluronsäure wird hauptsächlich in Schönheits- und Hautpflegeprodukten verwendet. Sie sorgt unter anderem für eine schnelle Wundheilung, reduziert Gesichtslinien, Falten und Hautalterung und heilt Schnitte und Verbrennungen. Sie enthält Vitamin C zur Aufhellung des Hauttons. Schönheitsprodukte mit Hyaluronsäure versorgen die Haut mit Nährstoffen, wenn sie unter anderem in Form von Feuchtigkeitscremes, Cremes, Hauttonern und Seren angewendet werden.
Data Bridge Market Research analysiert, dass der Markt für Hyaluronsäure im asiatisch-pazifischen Raum im Prognosezeitraum von 2023 bis 2030 voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 7,3 % wachsen und bis 2030 voraussichtlich 2.584,42 Millionen USD erreichen wird.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2023 bis 2030 |
|
Basisjahr |
2022 |
|
Historische Jahre |
2021 (anpassbar auf 2020–2016) |
|
Quantitative Einheiten |
Umsatz in Mio. USD |
|
Abgedeckte Segmente |
Nach Qualität (Kosmetikqualität und Pharmaqualität), Typ (Hydrolysierte Hyaluronsäure, Natriumacetylierte Hyaluronsäure und Natriumhyaluronat), Anwendung (Ästhetik, Osteoarthritis, Pharmazeutische API, Kosmetik, Augenheilkunde und Sonstiges), Endverbraucher (Medizinische Spas und Schönheitszentren, dermatologische Kliniken und Zentren für kosmetische Chirurgie), Vertriebskanal (Direktausschreibung und Einzelhandel). |
|
Abgedeckte Länder |
Japan, China, Südkorea, Indien, Australien, Singapur, Thailand, Malaysia, Indonesien, Philippinen und der Rest des asiatisch-pazifischen Raums. |
|
Abgedeckte Marktteilnehmer |
Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals im Besitz von Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services und Brickell Men's Products unter anderem |
Marktdefinition
Hyaluronsäure (HA), auch Hyaluronan genannt, ist ein anionisches, nicht sulfatiertes Glykosaminoglykan, das weit verbreitet im Binde-, Epithel- und Nervengewebe ist. Hyaluronsäure ist ein wesentlicher Bestandteil des Gelenkknorpels und umgibt jede Zelle im Knorpel wie eine Hülle (Chondrozyt). Die Robustheit des Knorpels beruht auf der Wasseraufnahme dieser Aggregate (ihrer Widerstandsfähigkeit gegen Kompression). Das Molekulargewicht (die Größe) von Hyaluronan im Knorpel nimmt mit dem Alter ab, aber die Menge nimmt zu. Der menschliche Körper enthält von Natur aus HA. Die größten Mengen an HA finden sich in den Gelenken und Augen. Die Chemikalie hat die Fähigkeit, eine strahlende, mit Feuchtigkeit versorgte Haut zu erhalten. Daher wird sie von vielen Schönheitschirurgen als Injektion verwendet, um die Zeichen der Hautalterung zu verzögern.
Die zunehmende Verbreitung minimalinvasiver Verfahren und das steigende Bewusstsein und die steigende Nachfrage nach Hyaluronsäure in pharmazeutischen und kosmetischen Produkten auf der ganzen Welt sind die Hauptantriebsfaktoren für das Marktwachstum im Prognosezeitraum. Der dramatische Anstieg der Forschungsqualität in Verbindung mit zunehmenden Forschungsmöglichkeiten ist auf verschiedene strategische Initiativen der Marktteilnehmer zurückzuführen. Sie ergreifen im Laufe der Jahre Initiativen wie Produkteinführungen, Kooperationen, Fusionen, Übernahmen und vieles mehr und werden voraussichtlich weitere Marktchancen schaffen.
Marktdynamik für Hyaluronsäure im asiatisch-pazifischen Raum
In diesem Abschnitt geht es um das Verständnis der Markttreiber, Vorteile, Chancen, Einschränkungen und Herausforderungen. All dies wird im Folgenden ausführlich erläutert:
TREIBER
- Steigendes Bewusstsein für kosmetische Injektionen oder Hautfüller
Hautfüller auf Hyaluronsäurebasis sind weniger invasive kosmetische Verfahren. Hautprobleme sind auf der ganzen Welt weit verbreitet. Es ist zu einem wichtigen Anliegen geworden, die Produkte zur Behandlung von Hautproblemen und zur Beseitigung von Hautfalten zu verstehen. Es wurden verschiedene Programme gestartet, um das Bewusstsein für die richtige Verwendung von Hyaluronsäure-Injektionen zu schärfen.
Das gesteigerte Bewusstsein wird es den Verbrauchern ermöglichen, sich für die richtige Behandlung von Akne und Falten zu entscheiden und das richtige Produkt (Botox-Injektion, Hautfüller) entsprechend der richtigen Ursache auszuwählen. Dies wird zu steigenden Umsätzen, einer Erweiterung des Produktportfolios und einer Erweiterung der Produktlinie führen. Dieser Faktor wird voraussichtlich das Marktwachstum vorantreiben.
- Verwendung invasiver Hautfüller auf Hyaluronsäurebasis
Hautfüller auf Hyaluronsäurebasis sind weniger invasive kosmetische Verfahren, die weltweit immer häufiger eingesetzt werden. Sie sind beliebte kosmetische Verfahren zur Gesichtserneuerung, Wiederherstellung des Gesichtsvolumens und zur ästhetischen Verbesserung.
Sie sind sehr vielseitig und werden bei feinen Linien und Fältchen eingesetzt. Darüber hinaus werden sie auch zur Behandlung von Akne, Fältchen und Narben sowie zur Lippen-, Wangen- und Kinnvergrößerung eingesetzt. Der Anstieg der geriatrischen Bevölkerung hat die Notwendigkeit nicht-invasiver chirurgischer Protokolle erhöht.
Der Einsatz von Hautfüllern auf Hyaluronsäurebasis wird die Wahrscheinlichkeit verringern, sich für eine normale Operation zu entscheiden. Die Behandlungskosten sind minimal und dieser Faktor wird das Marktwachstum ankurbeln.
Einschränkungen
- Verfügbarkeit nicht zugelassener oder alternativer Hautfüller behindert den Markt
Angesichts der weit verbreiteten Verfügbarkeit der ästhetischen Anwendung von Hautfüllern auf Hyaluronsäurebasis wird erwartet, dass mehrere limitierende Faktoren dieser Produkte das Marktwachstum im Asien-Pazifik-Raum in den kommenden Jahren hemmen werden.
Aufgrund der hohen Wirksamkeit, Patientenzufriedenheit und Anwendung bei dynamischen Fältchen ist Botulinumtoxin, ein Hautfüller, das weltweit führende nicht-chirurgische kosmetische Verfahren.
Darüber hinaus erfreuen sich andere biologisch abbaubare Füllstoffe wie Calciumhydroxylapatit (CaHA) und Poly-L-Milchsäure als alternative Füllstoffe für Implantate mit hoher Lebensdauer zunehmender Beliebtheit.
Ärzte zögern aufgrund der damit verbundenen Risiken, billige illegale Produkte zu verwenden. Umgekehrt wird die Verfügbarkeit illegaler Produkte im Bereich der Hautfüller den Preiswettbewerb verschärfen, insbesondere im Bereich der Hyaluronsäure. Größere Unternehmen, die hohe Preise pro Einheit anbieten, können konkurrieren, indem sie mehrere Produktpakete anbieten und Produkte in verschiedenen Produktabteilungen verkaufen.
Um die niedrigeren Preise für Hautfüller auf Hyaluronsäurebasis auszugleichen, müssen die Partikel- und Polymerhersteller die Produkte vermarkten. Die in diesem Segment verfügbaren Produkte variieren. Die Hersteller werden sich eher auf die Materialstärke der Hautfüller konzentrieren als auf den Selbstkostenpreis.
GELEGENHEITEN
- Neue Technologien und Entwicklungen bei Hyaluronsäureprodukten
Fortschrittliche innovative Technologien haben die ästhetische Behandlung der Haut und anderer Körperteile verbessert, wo immer dies erforderlich ist, und die Hautpflegebranche ist eine der sich am schnellsten verändernden Branchen. Inländische Marken mit Wirkstoffen, auf Inhaltsstoffen basierender Hautpflege und im Schönheitsbereich verzeichnen steigende Investitionen, und der Verbraucher ist stark involviert. Die fortschrittliche innovative Technologie und die Entwicklung von Produkten auf Hyaluronsäurebasis steigern die Nachfrage nach Hyaluronsäure auf dem Markt.
Hyaluron-Hautpflegeprodukte basieren auf Hyaluronsäure, die Unvollkommenheiten im Gesicht korrigiert, Volumen ausgleicht und bestimmte Gesichtspartien betont. Fortschritte bei Hautpflegeprodukten bieten eine effektive Möglichkeit, Gesichtszüge zu verbessern, wiederherzustellen und zu definieren. Fortschritte bei Produkten auf Hyaluronsäurebasis und Verfahren zur Anwendung von Hautfüllern ziehen Kunden in Richtung Kosmetik. Dies bedeutet, dass der technologische Fortschritt bei Hyaluron-Hautpflegeprodukten voraussichtlich eine Chance für Marktwachstum darstellen wird.
HERAUSFORDERUNGEN
- Eskalierender Produktrückruf
Der Rückruf von Produkten auf Hyaluronsäurebasis hat das Marktwachstum stark beeinträchtigt. Regulierungsbehörden rufen ästhetische und kosmetische Produkte aus Gesundheits- und Sicherheitsgründen zurück. Jedes Land hat seine eigene Regulierungsbehörde, die für die Überwachung der Regulierung von gesundheitsbezogenen Produkten verantwortlich ist.
Produktrückrufe seitens der Unternehmen oder Aufsichtsbehörden aufgrund von Bedenken hinsichtlich der gesundheitlichen Sicherheit der Patienten, wie etwa bei falschen Inhaltsstoffen oder Fehlern in den Inhaltsstoffen, sind nur einige der größten Bedenken, die das Marktwachstum behindern, da die Sicherheit und Gesundheit der Patienten für alle Märkte die wichtigsten Kriterien bei der Markteinführung ihrer Produkte sind.
Jüngste Entwicklungen
- Im Februar 2022 gab Allergan (eine Tochtergesellschaft von AbbVie Inc.) die FDA-Zulassung von JUVÉDERM VOLBELLA XC zur Verbesserung der Infraorbitalhöhlen bei Erwachsenen über 21 Jahren bekannt. Dies half dem Unternehmen, sein Produktportfolio im Bereich Ästhetik auf dem US-Markt zu erweitern.
- Im Februar 2021 kündigte Contipro, ein renommierter Hyaluronsäurehersteller mit Sitz in der Tschechischen Republik, die Einführung seines neuen Anti-Aging- und Anti-Akne-Behandlungsprodukts namens HyRetin an, das die Sichtbarkeit der Haut verbessert.
Marktumfang für Hyaluronsäure im asiatisch-pazifischen Raum
Der Markt für Hyaluronsäure im asiatisch-pazifischen Raum ist in fünf wichtige Segmente unterteilt, basierend auf Qualität, Typ, Anwendung, Endverbraucher und Vertriebskanal. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, um strategische Entscheidungen zur Identifizierung der wichtigsten Marktanwendungen zu treffen.
Grad
- Kosmetische Qualität
- Pharmazeutische Qualität
Basierend auf der Qualität ist der Markt in Kosmetikqualität und Pharmaqualität segmentiert.
Typ
- Hydrolysierte Hyaluronsäure
- Natriumacetylierte Hyaluronsäure
- Natriumhyaluronat
Je nach Typ ist der Markt in hydrolysierte Hyaluronsäure, natriumacetylierte Hyaluronsäure und Natriumhyaluronat segmentiert.
Anwendung
- Ästhetik
- Arthrose
- Pharmazeutische API
- Kosmetika
- Augenheilkunde
- Sonstiges
Basierend auf der Anwendung ist der Markt in Ästhetik, Osteoarthritis, pharmazeutische API, Kosmetik, Augenheilkunde und Sonstiges segmentiert.
Endbenutzer
- Pharmazeutische Industrie
- Dermatologische Kliniken
- Zentren für kosmetische Chirurgie
- Sonstiges
Basierend auf dem Endverbraucher ist der Markt in die Pharmaindustrie, dermatologische Kliniken, Zentren für kosmetische Chirurgie und andere segmentiert.
Vertriebskanal
- Direkte Ausschreibung
- Einzelhandelsumsätze
Basierend auf dem Vertriebskanal ist der Markt in Direktausschreibung und Einzelhandelsverkauf segmentiert.
Regionale Analyse/Einblicke für den Hyaluronsäuremarkt im asiatisch-pazifischen Raum
Der Hyaluronsäuremarkt im Asien-Pazifik-Raum wird analysiert und es werden Einblicke in die Marktgröße und Trends nach Land, Klasse, Typ, Anwendung, Endverbraucher und Vertriebskanal wie oben angegeben bereitgestellt.
Die in diesem Marktbericht abgedeckten Länder sind Japan, China, Südkorea, Indien, Australien, Singapur, Thailand, Malaysia, Indonesien, die Philippinen und der restliche asiatisch-pazifische Raum.
- Im Jahr 2023 dominiert Japan den Hyaluronsäuremarkt im asiatisch-pazifischen Raum in Bezug auf Marktanteil und Umsatz und wird seine Dominanz im Prognosezeitraum weiter ausbauen. Dies ist auf die wachsende Beliebtheit nicht-chirurgischer oder minimalinvasiver kosmetischer Verfahren zurückzuführen.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Marktvorschriften, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neu- und Ersatzverkäufe, demografische Daten des Landes, Krankheitsepidemiologie und Import- und Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Darüber hinaus werden bei der Prognoseanalyse der Länderdaten die Präsenz und Verfügbarkeit von Marken aus dem asiatisch-pazifischen Raum sowie ihre Herausforderungen aufgrund der Konkurrenz durch lokale und inländische Marken und die Auswirkungen der Vertriebskanäle berücksichtigt.
Wettbewerbsumfeld und Analyse der Marktanteile von Hyaluronsäure im asiatisch-pazifischen Raum
Die Wettbewerbslandschaft des Hyaluronsäuremarktes im asiatisch-pazifischen Raum bietet Einzelheiten zu den einzelnen Wettbewerbern. Die enthaltenen Einzelheiten umfassen Unternehmensübersicht, Unternehmensfinanzen, erzielten Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Präsenz im asiatisch-pazifischen Raum, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang sowie Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den Markt.
Zu den wichtigsten Akteuren auf dem Hyaluronsäuremarkt im asiatisch-pazifischen Raum zählen unter anderem Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals im Besitz von Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services und Brickell Men's Products.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC HYALURONIC ACID MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 GRADE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES
4.4 INDUSTRY INSIGHTS
5 REGULATORY FRAMEWORK
5.1 EGULATORY SCENARIO IN THE U.S.
5.2 REGULATORY SCENARIO IN EUROPE
5.3 REGULATORY SCENARIO IN CHINA
5.4 REGULATORY SCENARIO IN AUSTRALIA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS
6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS
6.1.3 RISE IN PRODUCT APPROVALS
6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES
6.2 RESTRAINTS
6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET
6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES
6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION
6.3 OPPORTUNITIES
6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS
6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.4 INCREASING RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 ESCALATING PRODUCT RECALL
6.4.2 LACK OF EXPERTISE
7 ASIA PACIFIC HYALURONIC ACID MARKET, BY GRADE
7.1 OVERVIEW
7.2 COSMETIC GRADE
7.2.1 GENDER
7.2.1.1 FEMALE PRODUCTS
7.2.1.2 MEN’S PRODUCT
7.2.2 PRODUCT TYPE
7.2.2.1 SKIN CARE
7.2.2.2 MAKEUP
7.2.2.3 CLEANSING
7.2.2.4 HAIR CARE
7.2.2.5 OTHERS
7.2.3 PROCEDURE
7.2.3.1 WRINKLE REMOVAL
7.2.3.2 SKIN SMOOTHENING
7.2.3.3 FACE LIFT
7.2.3.4 LIP AUGMENTATION
7.2.3.5 CHIN AUGMENTATION
7.2.3.6 FAT INJECTION
7.2.3.7 FACE LINE CORRECTION
7.2.3.8 ACNE SCAR TREATMENT
7.2.3.9 LIP PLUM
7.2.3.10 EAR LOBE REJUVENATION
7.2.3.11 LIPOATROPHY TREATMENT
7.2.3.12 OTHERS
7.3 PHARMACEUTICAL GRADE
7.3.1 TYPE
7.3.1.1 MEDICAL GRADE HYALURONIC ACID
7.3.1.2 INJECTION GRADE HYALURONIC ACID
7.3.2 PRODUCT TYPE
7.3.2.1 TOPICAL PREPARATIONS
7.3.2.2 INTRA-ARTICULAR INJECTION
7.3.2.2.1 PREFILLED INJECTIONS
7.3.2.2.2 VIAL
7.3.2.3 EYE DROPS
7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS
7.3.2.5 OTHERS
8 ASIA PACIFIC HYALURONIC ACID MARKET, BY TYPE
8.1 OVERVIEW
8.2 SODIUM HYALURONATE
8.2.1 MOLECULAR WEIGHT
8.2.1.1 HIGH MOLECULAR WEIGHT
8.2.1.2 LOW MOLECULAR WEIGHT
8.2.1.3 MEDIUM MOLECULAR WEIGHT
8.2.2 BY TYPE
8.2.2.1 COSMETIC GRADE
8.2.2.1.1 GENDER
8.2.2.1.1.1 FEMALE PRODUCTS
8.2.2.1.1.2 MEN'S PRODUCT
8.2.2.1.2 PRODUCT TYPE
8.2.2.1.2.1 SKIN CARE
8.2.2.1.2.2 MAKEUP
8.2.2.1.2.3 CLEANSING
8.2.2.1.2.4 HAIR CARE
8.2.2.1.2.5 OTHERS
8.2.2.2 PHARMACEUTICAL GRADE
8.2.2.2.1 TYPE
8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.2.2.2.2 PRODUCT TYPE
8.2.2.2.2.1 TOPICAL PREPARATIONS
8.2.2.2.2.2 INTRA-ARTICULAR INJECTION
8.2.2.2.2.2.1 PREFILLED INJECTIONS
8.2.2.2.2.2.2 VIAL
8.2.2.2.2.3 EYE DROPS
8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.2.2.2.2.5 OTHERS
8.3 HYDROLYZED HYALURONIC ACID
8.3.1 MOLECULAR WEIGHT
8.3.1.1 HIGH MOLECULAR WEIGHT
8.3.1.2 LOW MOLECULAR WEIGHT
8.3.1.3 MEDIUM MOLECULAR WEIGHT
8.3.2 BY TYPE
8.3.2.1 COSMETIC GRADE
8.3.2.1.1 GENDER
8.3.2.1.1.1 FEMALE PRODUCTS
8.3.2.1.1.2 MEN'S PRODUCT
8.3.2.1.2 PRODUCT TYPE
8.3.2.1.2.1 SKIN CARE
8.3.2.1.2.2 MAKEUP
8.3.2.1.2.3 CLEANSING
8.3.2.1.2.4 HAIR CARE
8.3.2.1.2.5 OTHERS
8.3.2.2 PHARMACEUTICAL GRADE
8.3.2.2.1 TYPE
8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.3.2.2.2 PRODUCT TYPE
8.3.2.2.2.1 TOPICAL PREPARATIONS
8.3.2.2.2.2 INTRA-ARTICULAR INJECTION
8.3.2.2.2.2.1 PREFILLED INJECTIONS
8.3.2.2.2.2.2 VIAL
8.3.2.2.2.3 EYE DROPS
8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.3.2.2.2.5 OTHERS
8.4 SODIUM ACETYLATED HYALURONIC ACID
8.4.1 MOLECULAR WEIGHT
8.4.1.1 HIGH MOLECULAR WEIGHT
8.4.1.2 LOW MOLECULAR WEIGHT
8.4.1.3 MEDIUM MOLECULAR WEIGHT
8.4.2 BY TYPE
8.4.2.1 COSMETIC GRADE
8.4.2.1.1 GENDER
8.4.2.1.1.1 FEMALE PRODUCTS
8.4.2.1.1.2 MEN'S PRODUCT
8.4.2.1.2 PRODUCT TYPE
8.4.2.1.2.1 SKIN CARE
8.4.2.1.2.2 MAKEUP
8.4.2.1.2.3 CLEANSING
8.4.2.1.2.4 HAIR CARE
8.4.2.1.2.5 OTHERS
8.4.2.2 PHARMACEUTICAL GRADE
8.4.2.2.1 TYPE
8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.4.2.2.2 PRODUCT TYPE
8.4.2.2.2.1 TOPICAL PREPARATIONS
8.4.2.2.2.2 INTRA-ARTICULAR INJECTION
8.4.2.2.2.2.1 PREFILLED INJECTIONS
8.4.2.2.2.2.2 VIAL
8.4.2.2.2.3 EYE DROPS
8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.4.2.2.2.5 OTHERS
9 ASIA PACIFIC HYALURONIC ACID MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 AESTHETICS
9.3 OSTEOARTHRITIS
9.4 COSMETICS
9.5 OPHTHALMOLOGY
9.6 PHARMACEUTICAL API
9.7 OTHERS
10 ASIA PACIFIC HYALURONIC ACID MARKET, BY END USER
10.1 OVERVIEW
10.2 DERMATOLOGY CLINICS
10.3 COSMETIC SURGERY CENTERS
10.4 MEDICAL SPAS AND BEAUTY CENTERS
10.5 OTHERS
11 ASIA PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL PHARMACY
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
12 ASIA PACIFIC HYALURONIC ACID MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 JAPAN
12.1.2 CHINA
12.1.3 SOUTH KOREA
12.1.4 INDIA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 REST OF ASIA-PACIFIC
13 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 FIDIA FARMACEUTICI S.P.A. (2022)
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBVIE INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 GALDERMA
15.4.1 COMPANY SNAPSHOT
15.4.2 COMPANY SHARE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 LG CHEM (2022)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 ABBOTT (2022)
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ANIKA THERAPEUTICS, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 COMPANY SHARE ANALYSIS
15.7.4 PRODUCT PORTFOLIO
15.7.5 RECENT DEVELOPMENTS
15.8 BIOSCIENCE GMBH
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOXIS PHARMACEUTICALS
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 BIOIBERICA S.A.U
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BOHUS BIOTECH AB
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 BRICKELL MEN'S PRODUCTS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CONTIPRO A.S.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 FILLMED
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GENESIS
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 HUONS
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 KEWPIE CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 LIFECORE BIOMEDICAL, INC.(2022)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 PROLLENIUM MEDICAL TECHNOLOGIES
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 RIVER PHARMA S.R.L.
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 SYMATESE
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 TEOXANE
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 VIRCHOW BIOTECH
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:
TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME
TABLE 3 ASIA PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 ASIA PACIFIC MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 ASIA PACIFIC DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 54 ASIA-PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 55 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 56 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 58 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 59 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 60 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 62 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 63 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 65 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 66 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 68 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 69 ASIA-PACIFIC HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 70 ASIA-PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 72 ASIA-PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 73 ASIA-PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 ASIA-PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 78 ASIA-PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 ASIA-PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 80 ASIA-PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 87 ASIA-PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 91 ASIA-PACIFIC HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 92 ASIA-PACIFIC HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 93 ASIA-PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 94 ASIA-PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 JAPAN HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 96 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 97 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 99 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 100 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 101 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 103 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 104 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 106 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 107 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 109 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 110 JAPAN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 111 JAPAN SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 112 JAPAN SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 JAPAN COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 114 JAPAN COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 JAPAN PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 JAPAN PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 JAPAN HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 119 JAPAN HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 JAPAN COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 121 JAPAN COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 JAPAN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 JAPAN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 JAPAN INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 JAPAN SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 126 JAPAN SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 JAPAN COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 128 JAPAN COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 JAPAN PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 JAPAN PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 JAPAN HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 133 JAPAN HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 JAPAN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 JAPAN RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 136 CHINA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 137 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 138 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 140 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 141 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 142 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 144 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 145 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 147 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 148 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 150 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 151 CHINA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 CHINA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 153 CHINA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 CHINA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 155 CHINA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 CHINA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 CHINA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 CHINA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 160 CHINA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 CHINA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 162 CHINA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 CHINA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 CHINA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 CHINA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 CHINA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 167 CHINA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 CHINA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 169 CHINA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 CHINA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 171 CHINA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 CHINA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 CHINA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 175 CHINA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 176 CHINA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 SOUTH KOREA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 178 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 179 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 181 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 182 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 183 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 185 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 186 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 188 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 189 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 191 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 192 SOUTH KOREA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 SOUTH KOREA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 194 SOUTH KOREA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 195 SOUTH KOREA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 196 SOUTH KOREA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 SOUTH KOREA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 201 SOUTH KOREA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 SOUTH KOREA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 203 SOUTH KOREA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 SOUTH KOREA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 SOUTH KOREA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 SOUTH KOREA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 SOUTH KOREA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 208 SOUTH KOREA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 SOUTH KOREA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 210 SOUTH KOREA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 SOUTH KOREA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 SOUTH KOREA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 SOUTH KOREA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 217 SOUTH KOREA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 218 INDIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 219 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 220 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 222 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 223 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 224 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 226 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 227 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 228 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 229 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 230 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 231 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 232 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 233 INDIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 234 INDIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 235 INDIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 236 INDIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 237 INDIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 INDIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 239 INDIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 INDIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 242 INDIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 243 INDIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 244 INDIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 245 INDIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 246 INDIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 INDIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 INDIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 249 INDIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 INDIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 251 INDIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 INDIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 INDIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 254 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 INDIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 256 INDIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 INDIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 258 INDIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 259 AUSTRALIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 260 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 261 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 263 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 264 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 265 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 266 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 267 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 268 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 270 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 271 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 273 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 274 AUSTRALIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 AUSTRALIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 276 AUSTRALIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 277 AUSTRALIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 278 AUSTRALIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 279 AUSTRALIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 280 AUSTRALIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 282 AUSTRALIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 283 AUSTRALIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 284 AUSTRALIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 285 AUSTRALIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 286 AUSTRALIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 AUSTRALIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 288 AUSTRALIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 289 AUSTRALIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 290 AUSTRALIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 291 AUSTRALIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 292 AUSTRALIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 293 AUSTRALIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 294 AUSTRALIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 295 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 AUSTRALIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 AUSTRALIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 298 AUSTRALIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 299 AUSTRALIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 300 SINGAPORE HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 301 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 302 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 303 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 304 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 305 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 306 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 307 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 308 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 309 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 311 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 312 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 313 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 314 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 315 SINGAPORE HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 316 SINGAPORE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 317 SINGAPORE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 SINGAPORE COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 319 SINGAPORE COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 320 SINGAPORE PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 321 SINGAPORE PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 323 SINGAPORE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 324 SINGAPORE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 325 SINGAPORE COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 326 SINGAPORE COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 SINGAPORE PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 328 SINGAPORE PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 SINGAPORE INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 SINGAPORE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 331 SINGAPORE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 332 SINGAPORE COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 333 SINGAPORE COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 334 SINGAPORE PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 SINGAPORE PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 336 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 337 SINGAPORE HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 338 SINGAPORE HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 339 SINGAPORE HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 340 SINGAPORE RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 341 THAILAND HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 342 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 343 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 345 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 346 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 347 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 348 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 349 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 350 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 351 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 352 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 353 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 354 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 355 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 356 THAILAND HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 357 THAILAND SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 358 THAILAND SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 359 THAILAND COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 360 THAILAND COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 361 THAILAND PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 362 THAILAND PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 363 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 364 THAILAND HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 365 THAILAND HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 THAILAND COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 367 THAILAND COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 368 THAILAND PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 369 THAILAND PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 370 THAILAND INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 371 THAILAND SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 372 THAILAND SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 373 THAILAND COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 374 THAILAND COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 375 THAILAND PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 376 THAILAND PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 377 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 THAILAND HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 379 THAILAND HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 380 THAILAND HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 381 THAILAND RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 382 MALAYSIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 383 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 384 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 386 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 387 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 388 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 389 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 390 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 391 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 392 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 393 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 394 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 395 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 396 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 397 MALAYSIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 MALAYSIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 399 MALAYSIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 400 MALAYSIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 401 MALAYSIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 402 MALAYSIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 403 MALAYSIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 405 MALAYSIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 406 MALAYSIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 407 MALAYSIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 408 MALAYSIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 409 MALAYSIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 410 MALAYSIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 411 MALAYSIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 412 MALAYSIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 413 MALAYSIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 414 MALAYSIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 415 MALAYSIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 416 MALAYSIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 417 MALAYSIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 418 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 419 MALAYSIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 MALAYSIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 421 MALAYSIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 422 MALAYSIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 423 INDONESIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 424 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 425 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 426 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 427 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 428 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 429 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 430 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 431 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 432 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 433 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 434 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 435 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 436 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 437 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 438 INDONESIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 439 INDONESIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 440 INDONESIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 441 INDONESIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 442 INDONESIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 443 INDONESIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 444 INDONESIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 445 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 446 INDONESIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 447 INDONESIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 448 INDONESIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 449 INDONESIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 450 INDONESIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 451 INDONESIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 452 INDONESIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 453 INDONESIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 454 INDONESIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 455 INDONESIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 456 INDONESIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 INDONESIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 458 INDONESIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 INDONESIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 461 INDONESIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 462 INDONESIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 463 INDONESIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 464 PHILIPPINES HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 465 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 466 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 467 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 468 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 469 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 470 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 471 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 472 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 473 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 474 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 475 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 476 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 477 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 478 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 479 PHILIPPINES HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 480 PHILIPPINES SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 481 PHILIPPINES SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 482 PHILIPPINES COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 483 PHILIPPINES COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 484 PHILIPPINES PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 485 PHILIPPINES PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 486 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 487 PHILIPPINES HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 488 PHILIPPINES HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 489 PHILIPPINES COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 490 PHILIPPINES COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 491 PHILIPPINES PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 PHILIPPINES PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 493 PHILIPPINES INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 494 PHILIPPINES SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 495 PHILIPPINES SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 496 PHILIPPINES COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 497 PHILIPPINES COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 498 PHILIPPINES PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 499 PHILIPPINES PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 500 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 501 PHILIPPINES HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 502 PHILIPPINES HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 503 PHILIPPINES HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 504 PHILIPPINES RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 505 REST OF ASIA-PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC HYALURONIC ACID MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC HYALURONIC ACID MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC HYALURONIC ACID MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC HYALURONIC ACID MARKET: DBMR POSITION GRID
FIGURE 8 ASIA PACIFIC HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC HYALURONIC ACID MARKET: END USER COVERAGE GRID
FIGURE 10 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE ASIA PACIFIC HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC HYALURONIC ACID MARKET
FIGURE 14 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, 2022
FIGURE 15 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)
FIGURE 16 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, 2022
FIGURE 19 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, 2022
FIGURE 23 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, 2022
FIGURE 27 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC HYALURONIC ACID MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC HYALURONIC ACID MARKET: GRADE (2023-2030)
FIGURE 39 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
